Open AccessCanagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug
Author(s) -
Sukanta Sen
Publication year - 2013
Publication title -
journal of drug delivery and therapeutics
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v3i3.490
Subject(s) - canagliflozin , renal glucose reabsorption , hypoglycemia , medicine , type 2 diabetes , drug , endocrinology , pharmacology , reabsorption , dapagliflozin , diabetes mellitus , kidney